Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Anteris Technologies Ltd (AVR.AX)

Anteris Technologies Ltd (AVR.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Anteris Technologies Ltd 9 Sherwood Road Level 3, Suite 302, Toowong Tower Toowong QLD 4066 AUS

https://www.anteristech.com P: 130-055-0310 F: 130-097-2437

Description:

Anteris Technologies Ltd is a structural heart company engaged in delivering clinically superior solutions that help healthcare professionals create life-changing outcomes for patients. The group's solutions include Anteris' DurAVR transcatheter heart valve for younger patients who need a heart valve that will last their lifetime, as well as DurAVR with its biomimetic design that replicates the normal blood flow of a healthy human aortic valve. It is also engaged in research and development of ComASUR, a delivery system that allows accurate valve placement, and the manufacturing and selling of proprietary ADAPT regenerative tissue products. The company generates a majority of its revenue from the United States and the rest from Switzerland and Australia.

Key Statistics

Overview:

Market Capitalization, $K 328,374
Shares Outstanding, K 21,140
Annual Sales, $ 4,111 K
Annual Net Income, $ -67,333 K
% of Institutional Shareholders 6.98%

Growth:

1-Year Return -53.63%
3-Year Return 0.56%
5-Year Return 4.07%
5-Year Revenue Growth -30.64%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -5.05
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 03/02/20

AVR.AX Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -655.53%
Return-on-Assets % -290.70%
Profit Margin % -1,637.85%
Debt/Equity 0.05
Price/Sales 39.87
Price/Book 57.81
Book Value/Share 0.15
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar